These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 15629041)
1. Isolation and characterization of 2'-amino-modified RNA aptamers for human TNFalpha. Yan X; Gao X; Zhang Z Genomics Proteomics Bioinformatics; 2004 Feb; 2(1):32-42. PubMed ID: 15629041 [TBL] [Abstract][Full Text] [Related]
2. [Screening and characterization of DNA aptamers with hTNF-alpha binding and neutralizing activity]. Guo KT; Yan XR; Huang GJ; Xu CX; Chai YS; Zhang ZQ Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):730-3. PubMed ID: 15971588 [TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of 2'-fluoro-, 2'-amino-, and 2'-fluoro-/amino-modified RNA ligands to human IFN-gamma that inhibit receptor binding. Kubik MF; Bell C; Fitzwater T; Watson SR; Tasset DM J Immunol; 1997 Jul; 159(1):259-67. PubMed ID: 9200462 [TBL] [Abstract][Full Text] [Related]
4. [Novel methods to detect cytokines by enzyme-linked oligonucleotide assay]. Yan XR; Gao XW; Yao LH; Zhang ZQ Sheng Wu Gong Cheng Xue Bao; 2004 Sep; 20(5):679-82. PubMed ID: 15973989 [TBL] [Abstract][Full Text] [Related]
5. Short bioactive Spiegelmers to migraine-associated calcitonin gene-related peptide rapidly identified by a novel approach: tailored-SELEX. Vater A; Jarosch F; Buchner K; Klussmann S Nucleic Acids Res; 2003 Nov; 31(21):e130. PubMed ID: 14576330 [TBL] [Abstract][Full Text] [Related]
6. Novel Human Three-Domain Antibody Fragments Against sTNFα as Well as tmTNFα with High Affinity Generated by the Combination of Ribosome Display and E. coli Expression System. Zhao XL; Tian LF; Zhang SJ; Li JM; Feng H; Wang LM; Wang S; Wang J; Wang T; Chen WQ Scand J Immunol; 2016 Apr; 83(4):267-78. PubMed ID: 26860639 [TBL] [Abstract][Full Text] [Related]
7. Capillary electrophoresis-systematic evolution of ligands by exponential enrichment selection of base- and sugar-modified DNA aptamers: target binding dominated by 2'-O,4'-C-methylene-bridged/locked nucleic acid primer. Kasahara Y; Irisawa Y; Fujita H; Yahara A; Ozaki H; Obika S; Kuwahara M Anal Chem; 2013 May; 85(10):4961-7. PubMed ID: 23662585 [TBL] [Abstract][Full Text] [Related]
8. High-affinity oligonucleotide ligands to human IgE inhibit binding to Fc epsilon receptor I. Wiegand TW; Williams PB; Dreskin SC; Jouvin MH; Kinet JP; Tasset D J Immunol; 1996 Jul; 157(1):221-30. PubMed ID: 8683119 [TBL] [Abstract][Full Text] [Related]
9. Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment). Joshi P; Prasad VR J Virol; 2002 Jul; 76(13):6545-57. PubMed ID: 12050367 [TBL] [Abstract][Full Text] [Related]
10. Calcium Influx of Mast Cells Is Inhibited by Aptamers Targeting the First Extracellular Domain of Orai1. Sun R; Yang Y; Ran X; Yang T PLoS One; 2016; 11(7):e0158223. PubMed ID: 27390850 [TBL] [Abstract][Full Text] [Related]
12. Cutting edge: novel RNA ligands able to bind CD4 antigen and inhibit CD4+ T lymphocyte function. Kraus E; James W; Barclay AN J Immunol; 1998 Jun; 160(11):5209-12. PubMed ID: 9605115 [TBL] [Abstract][Full Text] [Related]
13. TNFalpha kinoid vaccination-induced neutralizing antibodies to TNFalpha protect mice from autologous TNFalpha-driven chronic and acute inflammation. Le Buanec H; Delavallée L; Bessis N; Paturance S; Bizzini B; Gallo R; Zagury D; Boissier MC Proc Natl Acad Sci U S A; 2006 Dec; 103(51):19442-7. PubMed ID: 17158801 [TBL] [Abstract][Full Text] [Related]
14. RNA aptamers: from basic science towards therapy. Ulrich H Handb Exp Pharmacol; 2006; (173):305-26. PubMed ID: 16594622 [TBL] [Abstract][Full Text] [Related]
15. Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids. Macedo B; Cordeiro Y Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28513534 [TBL] [Abstract][Full Text] [Related]
16. Dual function of human necrosis factor receptor 75 in cytotoxicity induced by human tumor necrosis factor alpha. Fang J; Lu F; Chen CQ Acta Pharmacol Sin; 2001 Nov; 22(11):1039-44. PubMed ID: 11749798 [TBL] [Abstract][Full Text] [Related]
17. A novel human tumor necrosis factor alpha mutant showed potent antitumor activity and reduced toxicity in vivo. Lu F; Chen ZM; Liu QH; Chen CQ Acta Pharmacol Sin; 2001 Jul; 22(7):619-23. PubMed ID: 11749826 [TBL] [Abstract][Full Text] [Related]
18. Genetically engineered mesenchymal stromal cells producing TNFα have tumour suppressing effect on human melanoma xenograft. Tyciakova S; Matuskova M; Bohovic R; Polakova K; Toro L; Skolekova S; Kucerova L J Gene Med; 2015; 17(1-2):54-67. PubMed ID: 25677845 [TBL] [Abstract][Full Text] [Related]
19. Multivalent RNA aptamers that inhibit CTLA-4 and enhance tumor immunity. Santulli-Marotto S; Nair SK; Rusconi C; Sullenger B; Gilboa E Cancer Res; 2003 Nov; 63(21):7483-9. PubMed ID: 14612549 [TBL] [Abstract][Full Text] [Related]
20. SELEX Modifications and Bioanalytical Techniques for Aptamer-Target Binding Characterization. Tan SY; Acquah C; Sidhu A; Ongkudon CM; Yon LS; Danquah MK Crit Rev Anal Chem; 2016 Nov; 46(6):521-37. PubMed ID: 26980177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]